FDG Uptake by Prosthetic Arterial Grafts in Large Vessel Vasculitis Is Not Specific for Active Disease

This study investigated the incidence and clinical significance of arterial graft-associated uptake of fluorodeoxyglucose in large-vessel vasculitis (LVV). The role of 18F-labeled fluorodeoxyglucose-positron emission tomography/computed tomography ([18F]FDG-PET/CT) in the management of LVV remains t...

Full description

Saved in:
Bibliographic Details
Published inJACC. Cardiovascular imaging Vol. 10; no. 9; pp. 1042 - 1052
Main Authors Youngstein, Taryn, Tombetti, Enrico, Mukherjee, Jaita, Barwick, Tara D., Al-Nahhas, Adil, Humphreys, Emyr, Nash, Julian, Andrews, Jacqueline, Incerti, Elena, Tombolini, Elisabetta, Salerno, Annalaura, Sartorelli, Silvia, Ramirez, Giuseppe A., Papa, Maurizio, Sabbadini, Maria Grazia, Gianolli, Luigi, De Cobelli, Francesco, Fallanca, Federico, Baldissera, Elena, Manfredi, Angelo A., Picchio, Maria, Mason, Justin C.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.09.2017
Subjects
Online AccessGet full text
ISSN1936-878X
1876-7591
1876-7591
DOI10.1016/j.jcmg.2016.09.027

Cover

Abstract This study investigated the incidence and clinical significance of arterial graft-associated uptake of fluorodeoxyglucose in large-vessel vasculitis (LVV). The role of 18F-labeled fluorodeoxyglucose-positron emission tomography/computed tomography ([18F]FDG-PET/CT) in the management of LVV remains to be defined. Although [18F]FDG uptake at arterial graft sites raises concerns regarding active arteritis or infection, its clinical significance in LVV has never been formally studied. An observational prospective study sought to identify patients with Takayasu arteritis (TA) undergoing [18F]FDG-PET/CT more than 6 months after graft surgery from a large cohort of patients from 2 tertiary referral centers. [18F]FDG uptake by the graft and native arteries was scored on a scale of 0 to 3 relative to hepatic uptake, and periprosthetic maximum standardized uptake value (SUVmax) was calculated. Periprosthetic [18F]FDG uptake in active disease was compared with that in inactive disease, and arterial progression was assessed by prospective magnetic resonance angiography (MRA). Twenty-six subjects with TA were enrolled. All were afebrile with negative blood culture. Periprosthetic uptake was significant in 23 of 26 patients, and the mean SUVmax was 4.21 ± 1.46. Median periprosthetic [18F]FDG uptake score (3; interquartile range [IQR]: 3 to 3) was higher than in native aorta (1; IQR: 0 to 1; p < 0.001). Graft-specific [18F]FDG uptake was unrelated to disease activity. Despite the high frequency of graft-associated [18F]FDG uptake, sequential MRAs did not reveal arterial progression in 25 of 26 patients; the 1 remaining case showed minor progression limited to native arteries. Nine patients underwent repeated PET/CT scanning without showing changes in graft-specific uptake, despite increased treatment. Significant [18F]FDG uptake that is confined to arterial graft sites in patients with LVV does not reflect clinically relevant disease activity or progression. To minimize exposure to immunosuppression and in the face of negative blood culture, clinically quiescent arteritis, normal or stably raised C-reactive protein levels, we elected not to escalate treatment and monitor progression with MRA. [Display omitted]
AbstractList This study investigated the incidence and clinical significance of arterial graft-associated uptake of fluorodeoxyglucose in large-vessel vasculitis (LVV). The role of 18F-labeled fluorodeoxyglucose-positron emission tomography/computed tomography ([18F]FDG-PET/CT) in the management of LVV remains to be defined. Although [18F]FDG uptake at arterial graft sites raises concerns regarding active arteritis or infection, its clinical significance in LVV has never been formally studied. An observational prospective study sought to identify patients with Takayasu arteritis (TA) undergoing [18F]FDG-PET/CT more than 6 months after graft surgery from a large cohort of patients from 2 tertiary referral centers. [18F]FDG uptake by the graft and native arteries was scored on a scale of 0 to 3 relative to hepatic uptake, and periprosthetic maximum standardized uptake value (SUVmax) was calculated. Periprosthetic [18F]FDG uptake in active disease was compared with that in inactive disease, and arterial progression was assessed by prospective magnetic resonance angiography (MRA). Twenty-six subjects with TA were enrolled. All were afebrile with negative blood culture. Periprosthetic uptake was significant in 23 of 26 patients, and the mean SUVmax was 4.21 ± 1.46. Median periprosthetic [18F]FDG uptake score (3; interquartile range [IQR]: 3 to 3) was higher than in native aorta (1; IQR: 0 to 1; p < 0.001). Graft-specific [18F]FDG uptake was unrelated to disease activity. Despite the high frequency of graft-associated [18F]FDG uptake, sequential MRAs did not reveal arterial progression in 25 of 26 patients; the 1 remaining case showed minor progression limited to native arteries. Nine patients underwent repeated PET/CT scanning without showing changes in graft-specific uptake, despite increased treatment. Significant [18F]FDG uptake that is confined to arterial graft sites in patients with LVV does not reflect clinically relevant disease activity or progression. To minimize exposure to immunosuppression and in the face of negative blood culture, clinically quiescent arteritis, normal or stably raised C-reactive protein levels, we elected not to escalate treatment and monitor progression with MRA. [Display omitted]
This study investigated the incidence and clinical significance of arterial graft-associated uptake of fluorodeoxyglucose in large-vessel vasculitis (LVV). The role of F-labeled fluorodeoxyglucose-positron emission tomography/computed tomography ([ F]FDG-PET/CT) in the management of LVV remains to be defined. Although [ F]FDG uptake at arterial graft sites raises concerns regarding active arteritis or infection, its clinical significance in LVV has never been formally studied. An observational prospective study sought to identify patients with Takayasu arteritis (TA) undergoing [ F]FDG-PET/CT more than 6 months after graft surgery from a large cohort of patients from 2 tertiary referral centers. [ F]FDG uptake by the graft and native arteries was scored on a scale of 0 to 3 relative to hepatic uptake, and periprosthetic maximum standardized uptake value (SUV ) was calculated. Periprosthetic [ F]FDG uptake in active disease was compared with that in inactive disease, and arterial progression was assessed by prospective magnetic resonance angiography (MRA). Twenty-six subjects with TA were enrolled. All were afebrile with negative blood culture. Periprosthetic uptake was significant in 23 of 26 patients, and the mean SUV was 4.21 ± 1.46. Median periprosthetic [ F]FDG uptake score (3; interquartile range [IQR]: 3 to 3) was higher than in native aorta (1; IQR: 0 to 1; p < 0.001). Graft-specific [ F]FDG uptake was unrelated to disease activity. Despite the high frequency of graft-associated [ F]FDG uptake, sequential MRAs did not reveal arterial progression in 25 of 26 patients; the 1 remaining case showed minor progression limited to native arteries. Nine patients underwent repeated PET/CT scanning without showing changes in graft-specific uptake, despite increased treatment. Significant [ F]FDG uptake that is confined to arterial graft sites in patients with LVV does not reflect clinically relevant disease activity or progression. To minimize exposure to immunosuppression and in the face of negative blood culture, clinically quiescent arteritis, normal or stably raised C-reactive protein levels, we elected not to escalate treatment and monitor progression with MRA.
Abstract Objectives This study investigated the incidence and clinical significance of arterial graft-associated uptake of fluorodeoxyglucose in large-vessel vasculitis (LVV). Background The role of18 F-labeled fluorodeoxyglucose-positron emission tomography/computed tomography ([18 F]FDG-PET/CT) in the management of LVV remains to be defined. Although [18 F]FDG uptake at arterial graft sites raises concerns regarding active arteritis or infection, its clinical significance in LVV has never been formally studied. Methods An observational prospective study sought to identify patients with Takayasu arteritis (TA) undergoing [18 F]FDG-PET/CT more than 6 months after graft surgery from a large cohort of patients from 2 tertiary referral centers. [18 F]FDG uptake by the graft and native arteries was scored on a scale of 0 to 3 relative to hepatic uptake, and periprosthetic maximum standardized uptake value (SUVmax ) was calculated. Periprosthetic [18 F]FDG uptake in active disease was compared with that in inactive disease, and arterial progression was assessed by prospective magnetic resonance angiography (MRA). Results Twenty-six subjects with TA were enrolled. All were afebrile with negative blood culture. Periprosthetic uptake was significant in 23 of 26 patients, and the mean SUVmax was 4.21 ± 1.46. Median periprosthetic [18 F]FDG uptake score (3; interquartile range [IQR]: 3 to 3) was higher than in native aorta (1; IQR: 0 to 1; p < 0.001). Graft-specific [18 F]FDG uptake was unrelated to disease activity. Despite the high frequency of graft-associated [18 F]FDG uptake, sequential MRAs did not reveal arterial progression in 25 of 26 patients; the 1 remaining case showed minor progression limited to native arteries. Nine patients underwent repeated PET/CT scanning without showing changes in graft-specific uptake, despite increased treatment. Conclusions Significant [18 F]FDG uptake that is confined to arterial graft sites in patients with LVV does not reflect clinically relevant disease activity or progression. To minimize exposure to immunosuppression and in the face of negative blood culture, clinically quiescent arteritis, normal or stably raised C-reactive protein levels, we elected not to escalate treatment and monitor progression with MRA.
This study investigated the incidence and clinical significance of arterial graft-associated uptake of fluorodeoxyglucose in large-vessel vasculitis (LVV).OBJECTIVESThis study investigated the incidence and clinical significance of arterial graft-associated uptake of fluorodeoxyglucose in large-vessel vasculitis (LVV).The role of 18F-labeled fluorodeoxyglucose-positron emission tomography/computed tomography ([18F]FDG-PET/CT) in the management of LVV remains to be defined. Although [18F]FDG uptake at arterial graft sites raises concerns regarding active arteritis or infection, its clinical significance in LVV has never been formally studied.BACKGROUNDThe role of 18F-labeled fluorodeoxyglucose-positron emission tomography/computed tomography ([18F]FDG-PET/CT) in the management of LVV remains to be defined. Although [18F]FDG uptake at arterial graft sites raises concerns regarding active arteritis or infection, its clinical significance in LVV has never been formally studied.An observational prospective study sought to identify patients with Takayasu arteritis (TA) undergoing [18F]FDG-PET/CT more than 6 months after graft surgery from a large cohort of patients from 2 tertiary referral centers. [18F]FDG uptake by the graft and native arteries was scored on a scale of 0 to 3 relative to hepatic uptake, and periprosthetic maximum standardized uptake value (SUVmax) was calculated. Periprosthetic [18F]FDG uptake in active disease was compared with that in inactive disease, and arterial progression was assessed by prospective magnetic resonance angiography (MRA).METHODSAn observational prospective study sought to identify patients with Takayasu arteritis (TA) undergoing [18F]FDG-PET/CT more than 6 months after graft surgery from a large cohort of patients from 2 tertiary referral centers. [18F]FDG uptake by the graft and native arteries was scored on a scale of 0 to 3 relative to hepatic uptake, and periprosthetic maximum standardized uptake value (SUVmax) was calculated. Periprosthetic [18F]FDG uptake in active disease was compared with that in inactive disease, and arterial progression was assessed by prospective magnetic resonance angiography (MRA).Twenty-six subjects with TA were enrolled. All were afebrile with negative blood culture. Periprosthetic uptake was significant in 23 of 26 patients, and the mean SUVmax was 4.21 ± 1.46. Median periprosthetic [18F]FDG uptake score (3; interquartile range [IQR]: 3 to 3) was higher than in native aorta (1; IQR: 0 to 1; p < 0.001). Graft-specific [18F]FDG uptake was unrelated to disease activity. Despite the high frequency of graft-associated [18F]FDG uptake, sequential MRAs did not reveal arterial progression in 25 of 26 patients; the 1 remaining case showed minor progression limited to native arteries. Nine patients underwent repeated PET/CT scanning without showing changes in graft-specific uptake, despite increased treatment.RESULTSTwenty-six subjects with TA were enrolled. All were afebrile with negative blood culture. Periprosthetic uptake was significant in 23 of 26 patients, and the mean SUVmax was 4.21 ± 1.46. Median periprosthetic [18F]FDG uptake score (3; interquartile range [IQR]: 3 to 3) was higher than in native aorta (1; IQR: 0 to 1; p < 0.001). Graft-specific [18F]FDG uptake was unrelated to disease activity. Despite the high frequency of graft-associated [18F]FDG uptake, sequential MRAs did not reveal arterial progression in 25 of 26 patients; the 1 remaining case showed minor progression limited to native arteries. Nine patients underwent repeated PET/CT scanning without showing changes in graft-specific uptake, despite increased treatment.Significant [18F]FDG uptake that is confined to arterial graft sites in patients with LVV does not reflect clinically relevant disease activity or progression. To minimize exposure to immunosuppression and in the face of negative blood culture, clinically quiescent arteritis, normal or stably raised C-reactive protein levels, we elected not to escalate treatment and monitor progression with MRA.CONCLUSIONSSignificant [18F]FDG uptake that is confined to arterial graft sites in patients with LVV does not reflect clinically relevant disease activity or progression. To minimize exposure to immunosuppression and in the face of negative blood culture, clinically quiescent arteritis, normal or stably raised C-reactive protein levels, we elected not to escalate treatment and monitor progression with MRA.
Author Mukherjee, Jaita
Salerno, Annalaura
Manfredi, Angelo A.
Sartorelli, Silvia
Baldissera, Elena
Nash, Julian
Papa, Maurizio
Incerti, Elena
Andrews, Jacqueline
Tombetti, Enrico
Al-Nahhas, Adil
De Cobelli, Francesco
Ramirez, Giuseppe A.
Fallanca, Federico
Mason, Justin C.
Barwick, Tara D.
Sabbadini, Maria Grazia
Gianolli, Luigi
Youngstein, Taryn
Humphreys, Emyr
Tombolini, Elisabetta
Picchio, Maria
Author_xml – sequence: 1
  givenname: Taryn
  surname: Youngstein
  fullname: Youngstein, Taryn
  organization: Cardiovascular Sciences and Rheumatology Units, Imperial College Healthcare National Health Service Trust, London, United Kingdom
– sequence: 2
  givenname: Enrico
  surname: Tombetti
  fullname: Tombetti, Enrico
  organization: Cardiovascular Sciences and Rheumatology Units, Imperial College Healthcare National Health Service Trust, London, United Kingdom
– sequence: 3
  givenname: Jaita
  surname: Mukherjee
  fullname: Mukherjee, Jaita
  organization: Cardiovascular Sciences and Rheumatology Units, Imperial College Healthcare National Health Service Trust, London, United Kingdom
– sequence: 4
  givenname: Tara D.
  surname: Barwick
  fullname: Barwick, Tara D.
  organization: Imaging Department, Imperial College Healthcare National Health Service Trust, London, United Kingdom
– sequence: 5
  givenname: Adil
  surname: Al-Nahhas
  fullname: Al-Nahhas, Adil
  organization: Imaging Department, Imperial College Healthcare National Health Service Trust, London, United Kingdom
– sequence: 6
  givenname: Emyr
  surname: Humphreys
  fullname: Humphreys, Emyr
  organization: Prince Charles Hospital, Merthyr Tydfil, Wales
– sequence: 7
  givenname: Julian
  surname: Nash
  fullname: Nash, Julian
  organization: Rheumatology Unit, University Hospital Wales, Cardiff, Wales
– sequence: 8
  givenname: Jacqueline
  surname: Andrews
  fullname: Andrews, Jacqueline
  organization: Rheumatology Unit, Chapel Allerton Hospital, Leeds, United Kingdom
– sequence: 9
  givenname: Elena
  surname: Incerti
  fullname: Incerti, Elena
  organization: Unit of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy
– sequence: 10
  givenname: Elisabetta
  surname: Tombolini
  fullname: Tombolini, Elisabetta
  organization: Unit of Internal Medicine and Clinical Immunology, IRCCS San Raffaele Scientific Institute, Milan, Italy
– sequence: 11
  givenname: Annalaura
  surname: Salerno
  fullname: Salerno, Annalaura
  organization: Vita-Salute San Raffaele University, Milan, Italy
– sequence: 12
  givenname: Silvia
  surname: Sartorelli
  fullname: Sartorelli, Silvia
  organization: Unit of Internal Medicine and Clinical Immunology, IRCCS San Raffaele Scientific Institute, Milan, Italy
– sequence: 13
  givenname: Giuseppe A.
  surname: Ramirez
  fullname: Ramirez, Giuseppe A.
  organization: Unit of Internal Medicine and Clinical Immunology, IRCCS San Raffaele Scientific Institute, Milan, Italy
– sequence: 14
  givenname: Maurizio
  surname: Papa
  fullname: Papa, Maurizio
  organization: Unit of Radiology-Ville Turro, IRCCS San Raffaele Scientific Institute, Milan, Italy
– sequence: 15
  givenname: Maria Grazia
  surname: Sabbadini
  fullname: Sabbadini, Maria Grazia
  organization: Unit of Internal Medicine and Clinical Immunology, IRCCS San Raffaele Scientific Institute, Milan, Italy
– sequence: 16
  givenname: Luigi
  surname: Gianolli
  fullname: Gianolli, Luigi
  organization: Unit of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy
– sequence: 17
  givenname: Francesco
  surname: De Cobelli
  fullname: De Cobelli, Francesco
  organization: Vita-Salute San Raffaele University, Milan, Italy
– sequence: 18
  givenname: Federico
  surname: Fallanca
  fullname: Fallanca, Federico
  organization: Unit of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy
– sequence: 19
  givenname: Elena
  surname: Baldissera
  fullname: Baldissera, Elena
  organization: Unit of Internal Medicine and Clinical Immunology, IRCCS San Raffaele Scientific Institute, Milan, Italy
– sequence: 20
  givenname: Angelo A.
  surname: Manfredi
  fullname: Manfredi, Angelo A.
  organization: Unit of Internal Medicine and Clinical Immunology, IRCCS San Raffaele Scientific Institute, Milan, Italy
– sequence: 21
  givenname: Maria
  surname: Picchio
  fullname: Picchio, Maria
  organization: Unit of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy
– sequence: 22
  givenname: Justin C.
  surname: Mason
  fullname: Mason, Justin C.
  email: justin.mason@imperial.ac.uk
  organization: Cardiovascular Sciences and Rheumatology Units, Imperial College Healthcare National Health Service Trust, London, United Kingdom
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28109928$$D View this record in MEDLINE/PubMed
BookMark eNqFks1q3DAUhUVJaf76Al0ULbuxc2WPJauUwpA008DQFvJDd0KWr6dyPPZUkgPzNnmWPFlkJtkEmq7uXZzvXDjnHpK9fuiRkA8MUgaMn7Rpa9arNIt7CjKFTLwhB6wUPBGFZHtxlzlPSlH-3ieH3rcAHPhMvCP7WclAyqw8IKvzswW93gR9i7Ta0l9u8OEPBmvo3AV0Vnd04XQTPLU9XWq3QnqD3mNHb7Q3Y2eD9fTC0x9DeLi_3KCxTWSbwdG5CfYO6Zn1qD0ek7eN7jy-f5pH5Pr829Xp92T5c3FxOl8mpgAeEoSsEgXXKPOZrDlUUpZMzCoDkhWs0aXImkpjnTfCGFkLoevcMAZQMy0Am_yIfNr5btzwd0Qf1Np6g12nexxGr1jJWSFzCSJKPz5Jx2qNtdo4u9Zuq57DiYJyJzAxFe-wUcYGHezQB6dtpxioqQfVqqkHNfWgQKrYQ0SzF-iz-6vQlx2EMaA7i055Y7E3WFuHJqh6sK_jX1_gprO9Nbq7xS36dhhdH6NXTPlMgbqcvmN6DsZzkCJn0eDzvw3-d_0R_nPKSA
CitedBy_id crossref_primary_10_1007_s40674_019_00114_0
crossref_primary_10_3390_diagnostics12102565
crossref_primary_10_1093_rheumatology_keae635
crossref_primary_10_1016_j_jacc_2022_09_051
crossref_primary_10_1016_j_jcmg_2017_07_006
crossref_primary_10_1007_s00259_020_04871_2
crossref_primary_10_1111_1756_185X_13420
crossref_primary_10_35366_111350
crossref_primary_10_1007_s12350_018_1377_6
crossref_primary_10_1093_ehjci_jey197
crossref_primary_10_1097_BOR_0000000000000462
crossref_primary_10_1136_heartjnl_2022_321113
crossref_primary_10_1007_s11886_020_01372_4
crossref_primary_10_1038_s41598_020_59439_9
crossref_primary_10_1093_rheumatology_keab255
crossref_primary_10_1016_j_remn_2020_06_016
crossref_primary_10_1007_s00259_017_3639_y
crossref_primary_10_1016_j_semarthrit_2017_08_009
crossref_primary_10_1161_ATVBAHA_118_310957
crossref_primary_10_1016_j_jcmg_2016_10_010
crossref_primary_10_1016_j_jacr_2021_08_005
crossref_primary_10_1007_s00296_020_04551_2
crossref_primary_10_1093_rheumatology_key040
crossref_primary_10_1097_BOR_0000000000000459
crossref_primary_10_1038_s41598_019_48709_w
crossref_primary_10_1111_imr_12570
crossref_primary_10_1016_j_jcmg_2017_03_002
crossref_primary_10_1016_j_jcmg_2017_02_008
crossref_primary_10_2967_jnumed_122_265016
Cites_doi 10.1118/1.3635220
10.1016/j.jvs.2005.07.038
10.7326/0003-4819-120-11-199406010-00004
10.1016/j.jcmg.2011.04.020
10.1007/s00259-008-1002-z
10.1016/j.jcmg.2012.01.013
10.1002/jbm.a.20069
10.1093/rheumatology/ken119
10.1002/(SICI)1097-4636(20000315)49:4<489::AID-JBM7>3.0.CO;2-2
10.1002/art.24416
10.1016/j.ejvs.2015.06.007
10.1093/ejcts/ezs693
10.1007/s10067-012-2149-3
10.1093/rheumatology/kel323
10.1016/S1054-8807(98)00003-9
10.1002/art.33413
10.1007/s00259-003-1429-1
10.3109/14397595.2015.1012798
10.2967/jnumed.113.128173
10.1136/ard.2003.015701
10.2967/jnumed.108.053462
10.1097/BOR.0b013e32831cec7b
10.1007/s00259-014-2865-9
10.1007/s00259-011-1967-x
10.1038/nrrheum.2010.82
10.2967/jnumed.107.040253
10.1016/j.rcl.2007.05.012
ContentType Journal Article
Copyright 2017 American College of Cardiology Foundation
American College of Cardiology Foundation
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2017 American College of Cardiology Foundation
– notice: American College of Cardiology Foundation
– notice: Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.jcmg.2016.09.027
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1876-7591
EndPage 1052
ExternalDocumentID 28109928
10_1016_j_jcmg_2016_09_027
S1936878X16309731
1_s2_0_S1936878X16309731
Genre Multicenter Study
Research Support, Non-U.S. Gov't
Journal Article
Observational Study
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
18M
1B1
1P~
1~.
4.4
457
4G.
53G
5GY
5VS
7-5
8P~
AAEDT
AAEDW
AAIKJ
AALRI
AAOAW
AAQFI
AAXUO
AAYWO
ABBQC
ABFRF
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ACGFO
ACGFS
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEFWE
AEKER
AEUPX
AEVXI
AEXQZ
AFJKZ
AFPUW
AFRHN
AFTJW
AGCQF
AGHFR
AGYEJ
AIGII
AITUG
AJRQY
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
BAWUL
BLXMC
CS3
DIK
E3Z
EBS
EFKBS
EJD
F5P
FDB
FEDTE
FNPLU
GBLVA
H13
HVGLF
HZ~
IXB
J1W
M41
MO0
N9A
O-L
O9-
OAUVE
OA~
OK1
OL0
P-8
P-9
P2P
PC.
Q38
ROL
RPZ
SDF
SEL
SES
SSZ
W8F
Z5R
0SF
6I.
AACTN
AAFTH
ABVKL
AFCTW
AFETI
AJOXV
AMFUW
NCXOZ
RIG
T5K
AAIAV
EFLBG
LCYCR
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
~HD
ID FETCH-LOGICAL-c506t-e02b756ae9349d60b998174bc09151fa872fbaed3f7cc9d77ad3c1100d1a70ef3
IEDL.DBID .~1
ISSN 1936-878X
1876-7591
IngestDate Sat Sep 27 18:50:50 EDT 2025
Wed Feb 19 02:35:59 EST 2025
Tue Jul 01 00:39:15 EDT 2025
Thu Apr 24 22:59:20 EDT 2025
Fri Feb 23 02:34:21 EST 2024
Sun Feb 23 10:20:24 EST 2025
Tue Aug 26 16:32:32 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords CRP
GCA
SUV
MR angiography
[18F]FDG-PET/CT
arterial graft
large-vessel vasculitis
Takayasu arteritis
positron emission tomography
LVV
MRA
TA
C-reactive protein
18F-labeled fluorodeoxyglucose-positron emission tomography/computed tomography
standardized uptake value
giant-cell arteritis
[ 18F]FDG-PET/CT
magnetic resonance angiography
Language English
License This article is made available under the Elsevier license.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c506t-e02b756ae9349d60b998174bc09151fa872fbaed3f7cc9d77ad3c1100d1a70ef3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S1936878X16309731
PMID 28109928
PQID 1861593907
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_1861593907
pubmed_primary_28109928
crossref_citationtrail_10_1016_j_jcmg_2016_09_027
crossref_primary_10_1016_j_jcmg_2016_09_027
elsevier_sciencedirect_doi_10_1016_j_jcmg_2016_09_027
elsevier_clinicalkeyesjournals_1_s2_0_S1936878X16309731
elsevier_clinicalkey_doi_10_1016_j_jcmg_2016_09_027
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-09-01
PublicationDateYYYYMMDD 2017-09-01
PublicationDate_xml – month: 09
  year: 2017
  text: 2017-09-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JACC. Cardiovascular imaging
PublicationTitleAlternate JACC Cardiovasc Imaging
PublicationYear 2017
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Lee, Cho, Choi (bib10) 2012; 64
Spacek, Belohlavek, Votrubova, Sebesta, Stadler (bib23) 2009; 36
Keidar, Pirmisashvili, Leiderman, Nitecki, Israel (bib17) 2014; 55
Bettinardi, Presotto, Rapisarda, Picchio, Gianolli, Gilardi (bib16) 2011; 38
Blockmans, Coudyzer, Vanderschueren (bib18) 2008; 47
Tezuka, Haraguchi, Ishihara (bib11) 2012; 5
Kerr, Hallahan, Giordano (bib14) 1994; 120
Andrews, Al-Nahhas, Pennell (bib13) 2004; 63
Alibaz-Oner, Aydin, Direskeneli (bib8) 2013; 32
Alibaz-Oner, Dede, Ones, Turoglu, Direskeneli (bib12) 2015; 25
Keidar, Engel, Hoffman, Israel, Nitecki (bib22) 2007; 48
Berger, Vaartjes, Scholtens (bib19) 2015; 50
van Bilsen, Popa, Brouwer (bib27) 2004; 68
Arnaud, Haroche, Malek (bib9) 2009; 60
Kobayashi, Ishii, Oda (bib7) 2005; 46
Maschauer, Prante, Hoffmann, Deichen, Kuwert (bib28) 2004; 45
Blockmans, Bley, Schmidt (bib6) 2009; 21
Barwick, Lyons, Mikhaeel, Waltham, O'Doherty (bib15) 2014; 41
Salzmann, Kleinert, Berman, Williams (bib26) 1999; 8
Webb, Chambers, AL-Nahhas (bib3) 2004; 31
Andrews, Mason (bib4) 2007; 46
Tokuda, Oshima, Araki (bib24) 2013; 43
Fuchs, Briel, Daikeler (bib2) 2012; 39
Fukuchi, Ishida, Higashi (bib21) 2005; 42
Vucic, Dickson, Calcagno (bib29) 2011; 4
Hagerty, Salzmann, Kleinert, Williams (bib25) 2000; 49
Mason (bib1) 2010; 6
Walter (bib5) 2007; 45
Wasselius, Malmstedt, Kalin (bib20) 2008; 49
Walter (10.1016/j.jcmg.2016.09.027_bib5) 2007; 45
Hagerty (10.1016/j.jcmg.2016.09.027_bib25) 2000; 49
Keidar (10.1016/j.jcmg.2016.09.027_bib22) 2007; 48
Arnaud (10.1016/j.jcmg.2016.09.027_bib9) 2009; 60
Fuchs (10.1016/j.jcmg.2016.09.027_bib2) 2012; 39
Lee (10.1016/j.jcmg.2016.09.027_bib10) 2012; 64
Tezuka (10.1016/j.jcmg.2016.09.027_bib11) 2012; 5
Berger (10.1016/j.jcmg.2016.09.027_bib19) 2015; 50
Maschauer (10.1016/j.jcmg.2016.09.027_bib28) 2004; 45
Alibaz-Oner (10.1016/j.jcmg.2016.09.027_bib8) 2013; 32
Kerr (10.1016/j.jcmg.2016.09.027_bib14) 1994; 120
Andrews (10.1016/j.jcmg.2016.09.027_bib4) 2007; 46
Webb (10.1016/j.jcmg.2016.09.027_bib3) 2004; 31
Spacek (10.1016/j.jcmg.2016.09.027_bib23) 2009; 36
Blockmans (10.1016/j.jcmg.2016.09.027_bib18) 2008; 47
Vucic (10.1016/j.jcmg.2016.09.027_bib29) 2011; 4
Kobayashi (10.1016/j.jcmg.2016.09.027_bib7) 2005; 46
Alibaz-Oner (10.1016/j.jcmg.2016.09.027_bib12) 2015; 25
Mason (10.1016/j.jcmg.2016.09.027_bib1) 2010; 6
Andrews (10.1016/j.jcmg.2016.09.027_bib13) 2004; 63
Salzmann (10.1016/j.jcmg.2016.09.027_bib26) 1999; 8
Bettinardi (10.1016/j.jcmg.2016.09.027_bib16) 2011; 38
Barwick (10.1016/j.jcmg.2016.09.027_bib15) 2014; 41
Fukuchi (10.1016/j.jcmg.2016.09.027_bib21) 2005; 42
Wasselius (10.1016/j.jcmg.2016.09.027_bib20) 2008; 49
Tokuda (10.1016/j.jcmg.2016.09.027_bib24) 2013; 43
Blockmans (10.1016/j.jcmg.2016.09.027_bib6) 2009; 21
Keidar (10.1016/j.jcmg.2016.09.027_bib17) 2014; 55
van Bilsen (10.1016/j.jcmg.2016.09.027_bib27) 2004; 68
28473104 - JACC Cardiovasc Imaging. 2017 May;10(5):607-608
28473103 - JACC Cardiovasc Imaging. 2017 May;10(5):606-607
28882294 - JACC Cardiovasc Imaging. 2017 Sep;10(9):1085-1087
28109926 - JACC Cardiovasc Imaging. 2017 Sep;10(9):1053-1055
References_xml – volume: 46
  start-page: 917
  year: 2005
  end-page: 922
  ident: bib7
  article-title: Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT
  publication-title: J Nucl Med
– volume: 64
  start-page: 866
  year: 2012
  end-page: 875
  ident: bib10
  article-title: The role of 
  publication-title: Arthritis Rheum
– volume: 46
  start-page: 6
  year: 2007
  end-page: 15
  ident: bib4
  article-title: Takayasu's arteritis—recent advances in imaging offer promise
  publication-title: Rheumatology (Oxford)
– volume: 47
  start-page: 1179
  year: 2008
  end-page: 1184
  ident: bib18
  article-title: Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis
  publication-title: Rheumatology (Oxford)
– volume: 120
  start-page: 919
  year: 1994
  end-page: 929
  ident: bib14
  article-title: Takayasu arteritis
  publication-title: Ann Intern Med
– volume: 25
  start-page: 752
  year: 2015
  end-page: 755
  ident: bib12
  article-title: Patients with Takayasu's arteritis having persistent acute-phase response usually have an increased major vessel uptake by 18F-FDG-PET/CT
  publication-title: Mod Rheumatol
– volume: 42
  start-page: 919
  year: 2005
  end-page: 925
  ident: bib21
  article-title: Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomographic findings
  publication-title: J Vasc Surg
– volume: 68
  start-page: 423
  year: 2004
  end-page: 427
  ident: bib27
  article-title: Ongoing foreign body reaction to subcutaneous implanted (heparin) modified Dacron in rats
  publication-title: J Biomed Mater Res A
– volume: 50
  start-page: 376
  year: 2015
  end-page: 383
  ident: bib19
  article-title: Differential FDG-PET uptake patterns in uninfected and infected central prosthetic vascular grafts
  publication-title: Eur J Vasc Endovasc Surg
– volume: 41
  start-page: 2310
  year: 2014
  end-page: 2318
  ident: bib15
  article-title: 18F-FDG PET-CT uptake is a feature of both normal diameter and aneurysmal aortic wall and is not related to aneurysm size
  publication-title: Eur J Nucl Med Mol Imaging
– volume: 63
  start-page: 995
  year: 2004
  end-page: 1000
  ident: bib13
  article-title: Non-invasive imaging in the diagnosis and management of Takayasu's arteritis
  publication-title: Ann Rheum Dis
– volume: 45
  start-page: 735
  year: 2007
  end-page: 744
  ident: bib5
  article-title: [(18)F]fluorodeoxyglucose PET in large vessel vasculitis
  publication-title: Radiol Clin North Am
– volume: 49
  start-page: 489
  year: 2000
  end-page: 497
  ident: bib25
  article-title: Cellular proliferation and macrophage populations associated with implanted expanded polytetrafluoroethylene and polyethyleneterephthalate
  publication-title: J Biomed Mater Res
– volume: 31
  start-page: 627
  year: 2004
  end-page: 634
  ident: bib3
  article-title: The role of
  publication-title: Eur J Nucl Med Mol Imaging
– volume: 8
  start-page: 63
  year: 1999
  end-page: 71
  ident: bib26
  article-title: Inflammation and neovascularization associated with clinically used vascular prosthetic materials
  publication-title: Cardiovasc Pathol
– volume: 49
  start-page: 1601
  year: 2008
  end-page: 1605
  ident: bib20
  article-title: High 18F-FDG uptake in synthetic aortic vascular grafts on PET/CT in symptomatic and asymptomatic patients
  publication-title: J Nucl Med
– volume: 21
  start-page: 19
  year: 2009
  end-page: 28
  ident: bib6
  article-title: Imaging for large-vessel vasculitis
  publication-title: Curr Opin Rheumatol
– volume: 60
  start-page: 1193
  year: 2009
  end-page: 1200
  ident: bib9
  article-title: Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis?
  publication-title: Arthritis Rheum
– volume: 45
  start-page: 455
  year: 2004
  end-page: 460
  ident: bib28
  article-title: Characterization of 18F-FDG uptake in human endothelial cells in vitro
  publication-title: J Nucl Med
– volume: 48
  start-page: 1230
  year: 2007
  end-page: 1236
  ident: bib22
  article-title: Prosthetic vascular graft infection: the role of 18F-FDG PET/CT
  publication-title: J Nucl Med
– volume: 5
  start-page: 422
  year: 2012
  end-page: 429
  ident: bib11
  article-title: Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences
  publication-title: J Am Coll Cardiol Img
– volume: 43
  start-page: 1183
  year: 2013
  end-page: 1187
  ident: bib24
  article-title: Detection of thoracic aortic prosthetic graft infection with 
  publication-title: Eur J Cardiothorac Surg
– volume: 6
  start-page: 406
  year: 2010
  end-page: 415
  ident: bib1
  article-title: Takayasu arteritis—advances in diagnosis and management
  publication-title: Nat Rev Rheumatol
– volume: 36
  start-page: 850
  year: 2009
  end-page: 858
  ident: bib23
  article-title: Diagnostics of “non-acute” vascular prosthesis infection using
  publication-title: Eur J Nucl Med Mol Imaging
– volume: 32
  start-page: 541
  year: 2013
  end-page: 546
  ident: bib8
  article-title: Advances in the diagnosis, assessment and outcome of Takayasu's arteritis
  publication-title: Clin Rheumatol
– volume: 4
  start-page: 1100
  year: 2011
  end-page: 1109
  ident: bib29
  article-title: Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging
  publication-title: J Am Coll Cardiol Img
– volume: 38
  start-page: 5394
  year: 2011
  end-page: 5411
  ident: bib16
  article-title: Physical performance of the new hybrid PETCT Discovery-690
  publication-title: Med Phys
– volume: 39
  start-page: 344
  year: 2012
  end-page: 353
  ident: bib2
  article-title: The impact of (18)F-FDG PET on the management of patients with suspected large vessel vasculitis
  publication-title: Eur J Nucl Med Mol Imaging
– volume: 55
  start-page: 392
  year: 2014
  end-page: 395
  ident: bib17
  article-title: 18F-FDG uptake in noninfected prosthetic vascular grafts: incidence, patterns, and changes over time
  publication-title: J Nucl Med
– volume: 38
  start-page: 5394
  year: 2011
  ident: 10.1016/j.jcmg.2016.09.027_bib16
  article-title: Physical performance of the new hybrid PETCT Discovery-690
  publication-title: Med Phys
  doi: 10.1118/1.3635220
– volume: 42
  start-page: 919
  year: 2005
  ident: 10.1016/j.jcmg.2016.09.027_bib21
  article-title: Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomographic findings
  publication-title: J Vasc Surg
  doi: 10.1016/j.jvs.2005.07.038
– volume: 120
  start-page: 919
  year: 1994
  ident: 10.1016/j.jcmg.2016.09.027_bib14
  article-title: Takayasu arteritis
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-120-11-199406010-00004
– volume: 4
  start-page: 1100
  year: 2011
  ident: 10.1016/j.jcmg.2016.09.027_bib29
  article-title: Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging
  publication-title: J Am Coll Cardiol Img
  doi: 10.1016/j.jcmg.2011.04.020
– volume: 36
  start-page: 850
  year: 2009
  ident: 10.1016/j.jcmg.2016.09.027_bib23
  article-title: Diagnostics of “non-acute” vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-008-1002-z
– volume: 5
  start-page: 422
  year: 2012
  ident: 10.1016/j.jcmg.2016.09.027_bib11
  article-title: Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences
  publication-title: J Am Coll Cardiol Img
  doi: 10.1016/j.jcmg.2012.01.013
– volume: 68
  start-page: 423
  year: 2004
  ident: 10.1016/j.jcmg.2016.09.027_bib27
  article-title: Ongoing foreign body reaction to subcutaneous implanted (heparin) modified Dacron in rats
  publication-title: J Biomed Mater Res A
  doi: 10.1002/jbm.a.20069
– volume: 47
  start-page: 1179
  year: 2008
  ident: 10.1016/j.jcmg.2016.09.027_bib18
  article-title: Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/ken119
– volume: 45
  start-page: 455
  year: 2004
  ident: 10.1016/j.jcmg.2016.09.027_bib28
  article-title: Characterization of 18F-FDG uptake in human endothelial cells in vitro
  publication-title: J Nucl Med
– volume: 49
  start-page: 489
  year: 2000
  ident: 10.1016/j.jcmg.2016.09.027_bib25
  article-title: Cellular proliferation and macrophage populations associated with implanted expanded polytetrafluoroethylene and polyethyleneterephthalate
  publication-title: J Biomed Mater Res
  doi: 10.1002/(SICI)1097-4636(20000315)49:4<489::AID-JBM7>3.0.CO;2-2
– volume: 60
  start-page: 1193
  year: 2009
  ident: 10.1016/j.jcmg.2016.09.027_bib9
  article-title: Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis?
  publication-title: Arthritis Rheum
  doi: 10.1002/art.24416
– volume: 50
  start-page: 376
  year: 2015
  ident: 10.1016/j.jcmg.2016.09.027_bib19
  article-title: Differential FDG-PET uptake patterns in uninfected and infected central prosthetic vascular grafts
  publication-title: Eur J Vasc Endovasc Surg
  doi: 10.1016/j.ejvs.2015.06.007
– volume: 43
  start-page: 1183
  year: 2013
  ident: 10.1016/j.jcmg.2016.09.027_bib24
  article-title: Detection of thoracic aortic prosthetic graft infection with 18F-fluorodeoxyglucose positron emission tomography/computed tomography
  publication-title: Eur J Cardiothorac Surg
  doi: 10.1093/ejcts/ezs693
– volume: 32
  start-page: 541
  year: 2013
  ident: 10.1016/j.jcmg.2016.09.027_bib8
  article-title: Advances in the diagnosis, assessment and outcome of Takayasu's arteritis
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-012-2149-3
– volume: 46
  start-page: 6
  year: 2007
  ident: 10.1016/j.jcmg.2016.09.027_bib4
  article-title: Takayasu's arteritis—recent advances in imaging offer promise
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kel323
– volume: 8
  start-page: 63
  year: 1999
  ident: 10.1016/j.jcmg.2016.09.027_bib26
  article-title: Inflammation and neovascularization associated with clinically used vascular prosthetic materials
  publication-title: Cardiovasc Pathol
  doi: 10.1016/S1054-8807(98)00003-9
– volume: 64
  start-page: 866
  year: 2012
  ident: 10.1016/j.jcmg.2016.09.027_bib10
  article-title: The role of 18F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with Takayasu arteritis
  publication-title: Arthritis Rheum
  doi: 10.1002/art.33413
– volume: 31
  start-page: 627
  year: 2004
  ident: 10.1016/j.jcmg.2016.09.027_bib3
  article-title: The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-003-1429-1
– volume: 25
  start-page: 752
  year: 2015
  ident: 10.1016/j.jcmg.2016.09.027_bib12
  article-title: Patients with Takayasu's arteritis having persistent acute-phase response usually have an increased major vessel uptake by 18F-FDG-PET/CT
  publication-title: Mod Rheumatol
  doi: 10.3109/14397595.2015.1012798
– volume: 55
  start-page: 392
  year: 2014
  ident: 10.1016/j.jcmg.2016.09.027_bib17
  article-title: 18F-FDG uptake in noninfected prosthetic vascular grafts: incidence, patterns, and changes over time
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.113.128173
– volume: 63
  start-page: 995
  year: 2004
  ident: 10.1016/j.jcmg.2016.09.027_bib13
  article-title: Non-invasive imaging in the diagnosis and management of Takayasu's arteritis
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2003.015701
– volume: 49
  start-page: 1601
  year: 2008
  ident: 10.1016/j.jcmg.2016.09.027_bib20
  article-title: High 18F-FDG uptake in synthetic aortic vascular grafts on PET/CT in symptomatic and asymptomatic patients
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.108.053462
– volume: 21
  start-page: 19
  year: 2009
  ident: 10.1016/j.jcmg.2016.09.027_bib6
  article-title: Imaging for large-vessel vasculitis
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/BOR.0b013e32831cec7b
– volume: 41
  start-page: 2310
  year: 2014
  ident: 10.1016/j.jcmg.2016.09.027_bib15
  article-title: 18F-FDG PET-CT uptake is a feature of both normal diameter and aneurysmal aortic wall and is not related to aneurysm size
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-014-2865-9
– volume: 39
  start-page: 344
  year: 2012
  ident: 10.1016/j.jcmg.2016.09.027_bib2
  article-title: The impact of (18)F-FDG PET on the management of patients with suspected large vessel vasculitis
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-011-1967-x
– volume: 46
  start-page: 917
  year: 2005
  ident: 10.1016/j.jcmg.2016.09.027_bib7
  article-title: Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT
  publication-title: J Nucl Med
– volume: 6
  start-page: 406
  year: 2010
  ident: 10.1016/j.jcmg.2016.09.027_bib1
  article-title: Takayasu arteritis—advances in diagnosis and management
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2010.82
– volume: 48
  start-page: 1230
  year: 2007
  ident: 10.1016/j.jcmg.2016.09.027_bib22
  article-title: Prosthetic vascular graft infection: the role of 18F-FDG PET/CT
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.107.040253
– volume: 45
  start-page: 735
  year: 2007
  ident: 10.1016/j.jcmg.2016.09.027_bib5
  article-title: [(18)F]fluorodeoxyglucose PET in large vessel vasculitis
  publication-title: Radiol Clin North Am
  doi: 10.1016/j.rcl.2007.05.012
– reference: 28473103 - JACC Cardiovasc Imaging. 2017 May;10(5):606-607
– reference: 28882294 - JACC Cardiovasc Imaging. 2017 Sep;10(9):1085-1087
– reference: 28473104 - JACC Cardiovasc Imaging. 2017 May;10(5):607-608
– reference: 28109926 - JACC Cardiovasc Imaging. 2017 Sep;10(9):1053-1055
SSID ssj0060647
Score 2.342156
Snippet This study investigated the incidence and clinical significance of arterial graft-associated uptake of fluorodeoxyglucose in large-vessel vasculitis (LVV). The...
Abstract Objectives This study investigated the incidence and clinical significance of arterial graft-associated uptake of fluorodeoxyglucose in large-vessel...
This study investigated the incidence and clinical significance of arterial graft-associated uptake of fluorodeoxyglucose in large-vessel vasculitis...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1042
SubjectTerms Adolescent
Adult
arterial graft
Arteries - diagnostic imaging
Arteries - surgery
Blood Vessel Prosthesis
Blood Vessel Prosthesis Implantation - adverse effects
Blood Vessel Prosthesis Implantation - instrumentation
Cardiovascular
Cross-Sectional Studies
Female
Fluorodeoxyglucose F18 - administration & dosage
Humans
Italy
large-vessel vasculitis
London
Magnetic Resonance Angiography
Male
Middle Aged
MR angiography
positron emission tomography
Positron Emission Tomography Computed Tomography
Predictive Value of Tests
Prospective Studies
Radiopharmaceuticals - administration & dosage
Takayasu arteritis
Tertiary Care Centers
Time Factors
Treatment Outcome
Vasculitis - diagnostic imaging
Vasculitis - etiology
Young Adult
Title FDG Uptake by Prosthetic Arterial Grafts in Large Vessel Vasculitis Is Not Specific for Active Disease
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1936878X16309731
https://www.clinicalkey.es/playcontent/1-s2.0-S1936878X16309731
https://dx.doi.org/10.1016/j.jcmg.2016.09.027
https://www.ncbi.nlm.nih.gov/pubmed/28109928
https://www.proquest.com/docview/1861593907
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqHhAXxJvlJSNxQ2EdO7GTY2nZtohWSLDV3iy_UraU7KpJD1z4LfwWfhkzjrMSohSJSw6RJ04mM-PPmm_GhLx03lsmSpGxJsissBJ8jiPtzzRFYayVIWDt8NGxPJgX7xblYovsjrUwSKtMsX-I6TFapzvTpM3permcfgToIStVLQBRYM-ZWMFeKLT11983NA-JxZRDZllmODoVzgwcrzP39RTpXTL2OsWTZa5enP4GPuMiNLtNbiX0SHeGF7xDtkJ7l9w4Svnxe-R0trdP5-vefAnUfqMfsKTjM5Ypoki0Nbp_YZq-o8uWvkcSOD3B5uHn9CQyUrHBET3s6PGq__kjHk3fgCzgWroT4yLdG_I598l89vbT7kGWjlLIXMlknwXGrSqlCbUoai-ZhV0W7EWsA7hQ5o2pFG-sCV40yrnaK2W8cNhNzudGsdCIB2S7XbXhEaEucOUN4jYL6EMw0-ROwjNlLXlRST8h-ahD7VKfcTzu4lyPhLIzjXrXqHfNag16n5BXG5n10GXj2tFi_DV6rB-FiKdhEbhWSl0lFbrktJ3Odcc1038Y1oSUG8nfbPOfM74Y7UaD02ImxrRhdQkzVQAka1EzGPNwMKjNd_MKk5W8evyfsz4hNzlCj8iDe0q2-4vL8AyAU2-fR8-A6-HizS-NShZp
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5VRQIuiDcpr0XihqysX7v2sbSkCSQREk2V22pfLimtE9XugX_Db-GXMbNeR0KUInGNdrzOeGb2W803M4S8NdZqluZpxCrHo0xz8LkEaX-qyjKlNXcOa4dncz5eZB-X-XKHHPS1MEirDLG_i-k-WodfhkGbw81qNfwC0IMXolgCosCeM3AFugVogKFpT5bv-3DMsZqySy3zCJeHypmO5HVmLk6R38V9s1McLXP96fQ39OlPodF9ci_AR7rfveEDsuPqh-T2LCTIH5HT0eERXWxa9c1R_Z1-xpqOr1iniCLe2OjRparahq5qOkUWOD3B7uHn9MRTUrHDEZ00dL5uf_7ws-krkAVgS_d9YKSHXULnMVmMPhwfjKMwSyEyOeNt5FiiRc6VK9OstJxpuGbBZUQbwAt5XKlCJJVWzqaVMKa0QiibGmwnZ2MlmKvSJ2S3XtfuGaHGJcIqBG4a4EfKVBUbDs_kJU-ygtsBiXsdShMajeO8i3PZM8rOJOpdot4lKyXofUDebWU2XZuNG1en_aeRfQEphDwJp8CNUuI6KdcEr21kLJtEMvmHZQ1IvpX8zTj_ueOb3m4keC2mYlTt1lewUwFIskxLBmuedga1_d9JgdnKpNj7z11fkzvj49lUTifzT8_J3QRxiCfFvSC77eWVewkoqtWvvJf8AhJHGJI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=FDG+Uptake+by+Prosthetic+Arterial+Grafts+in+Large+Vessel+Vasculitis+Is+Not%C2%A0Specific+for+Active+Disease&rft.jtitle=JACC.+Cardiovascular+imaging&rft.au=Youngstein%2C+Taryn&rft.au=Tombetti%2C+Enrico&rft.au=Mukherjee%2C+Jaita&rft.au=Barwick%2C+Tara+D&rft.date=2017-09-01&rft.eissn=1876-7591&rft.volume=10&rft.issue=9&rft.spage=1042&rft_id=info:doi/10.1016%2Fj.jcmg.2016.09.027&rft_id=info%3Apmid%2F28109928&rft.externalDocID=28109928
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1936-878X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1936-878X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1936-878X&client=summon